Early-Stage R33 Trials for Pharmacologic or Neuromodulatory Device Treatments for Mental Illness (Clinical Trial Required)
This NOFO funds single-phase, early-stage clinical trials testing pharmacologic agents with novel mechanisms or neuromodulatory devices to treat symptoms or functional domains in people with mental illness, including prodromal cases. Proposals must test the presumed mechanism of action and demonstrate dose-dependent neurophysiological, clinical, or behavioral effects. Studies may target pediat…
In the last several years, pharmaceutical companies have shifted their focus away from psychiatric indications, due to the high failure rate of drug approvals, with many of the failures occurring in late stage development after significant funding and testing had occurred. Likewise, a handful of…
Funding Source
Awards & funding
Eligibility
- Foreign entities: Non-domestic (non-U.S.) entities (foreign organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
- Required registrations …
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers